Tag Archives: CXCR4

Eckert & Ziegler to Supply Clinical-Grade Y90-PentixaTher Doses for Pentixapharm Trials

(IN BRIEF) Eckert & Ziegler Radiopharma GmbH has entered into a clinical manufacturing agreement with Pentixapharm AG to supply GMP-grade Y90-PentixaTher doses for use in ongoing trials. The radiolabeled therapy targets cancers overexpressing the CXCR4 receptor and supports a theranostic … Read the full press release